Results 171 to 180 of about 115,605 (312)
Pleural effusion associated with urinary tract obstruction: support for a hypothesis. [PDF]
Fkl Leung+2 more
openalex +1 more source
The sandwiched pleural effusion
Uma Maheswari Krishnaswamy+5 more
openaire +3 more sources
Respiratory improvement of aspiration pneumonia using high‐flow oxygen therapy in a cat
Abstract A 13‐year‐old neutered male cat was presented with acute paraparesis and severe thoracolumbar pain. Magnetic resonance imaging revealed an extradural paraspinal mass compressing the spinal cord. Surgery was performed, but 20 h post‐operatively, the cat developed severe respiratory distress consistent with aspiration pneumonia.
Vanessa Neubert+2 more
wiley +1 more source
Metagenomic and Metabolomic Profiling Reveals the Impact of High-Fat Diet on Malignant Pleural Effusion. [PDF]
Chen QY+4 more
europepmc +1 more source
Treatment of Malignant Pleural Effusion: A Method Using Tube Thoracostomy and Talc
Richard H. Adler, İskender Sayek
openalex +1 more source
Iatrogenic pulsus alternans in a dog undergoing median sternotomy
Abstract A 6‐year‐old, 21.8 kg, female, spayed Siberian husky was referred for management of a spontaneous bilateral pneumothorax, due to a ruptured pulmonary bleb. During surgery, sterile saline was instilled on three occasions in order to locate the damaged lung tissue and ensure complete ligation.
Marie‐Line Doï+2 more
wiley +1 more source
Diagnostic accuracy of interleukin 32γ for tuberculous pleural effusion. [PDF]
Wang Q+5 more
europepmc +1 more source
Abstract Background Thermal ablation is effective for early‐stage hepatocellular carcinoma (HCC). It can induce a host immune response through dynamic changes in serum cytokines. It is unknown whether this host immune response correlates with tumour recurrence.
Kelvin K. C. Ng+3 more
wiley +1 more source
Driver mutations and malignant pleural effusion in non-small cell lung cancer. [PDF]
Temel U, Derdiyok O.
europepmc +1 more source
Are two drugs better than one in advanced NSCLC? ABSTRACT Background Randomized studies have demonstrated superior overall survival (OS) of pembrolizumab (pembro), both alone and in combination with chemotherapy (chemo) over chemo alone in patients with programmed cell death ligand‐1 (PD‐L1) ≥ 50% advanced non–small cell lung cancer (NSCLC).
Junipearl Cheng+5 more
wiley +1 more source